 Home > Medical News > Latest Medical News > Novo Nordisk reached a settlement for $100 million in shareholder class action insulin pricing opaque

Novo Nordisk reached a settlement for $100 million in shareholder class action insulin pricing opaque

 Last Update: 2021-11-05
 Source: Internet
 Author: User

Tags

high pressure steam

drugs used

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationAspirin

On September 24, 2021, in a 2017 lawsuit filed in the Federal District Court of New Jersey after shareholders claimed that the insulin pricing disclosed by them was opaque, Novo Nordisk agreed to pay the plaintiff a settlement agreement of US$100 million

Although the Danish drugmaker agreed to pay a huge sum of money to settle the lawsuit, it insisted that the move was not an admission of wrongdoing

About 260 pension fund companies file class actions

This is a class action filed by about 260 pension fund companies, claiming a total of 11.

The plaintiff believes that Novo Nordisk failed to truthfully disclose all the truth behind the company's increased revenue in the United States between 2015 and 2017

These pension fund management companies are all purchasers of American Depository Receipts (ADR)

The price war for insulin

In the United States, the relationship between pharmaceutical manufacturers and pharmacy welfare managers (PBM) has always been in love and killing each other.

PBM is mainly responsible for the development and maintenance of formulary, signing contracts with pharmacies, negotiating discounts and rebates with pharmaceutical companies, and processing and paying for prescription drug claims, such as CVS's Caremark and MedImpact Healthcare Systems

Reference source:

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.